Huiqiang Zhou
GlaxoSmithKline (United States) · 24 works · 689 citations · h-index 15
Top works
- N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as Potent and Selective Inhibitors of Glycogen Synthase Kinase 3 with Good Cellular Efficacy
- Novel pyrazolopyrimidine derivatives as GSK-3 inhibitors
- Melanin-Concentrating Hormone-1 Receptor Antagonists for the Treatment of Obesity
- Application of Phosphoramidate ProTide Technology Significantly Improves Antiviral Potency of Carbocyclic Adenosine Derivatives
- Design of Potent, Selective, and Orally Bioavailable Inhibitors of Cysteine Protease Cathepsin K
- P2–P3 conformationally constrained ketoamide-based inhibitors of cathepsin K
- The discovery and optimization of pyrimidinone-containing MCH R1 antagonists
- Control over the Localization of Positive Charge in DNA: The Effect on Duplex DNA and RNA Stability
- Orally bioavailable small molecule ketoamide-based inhibitors of cathepsin K
- Studies on the Inactivation of Bovine Liver Enoyl-CoA Hydratase by (Methylenecyclopropyl)formyl-CoA: Elucidation of the Inactivation Mechanism and Identification of Cysteine-114 as the Entrapped Nucleophile
- Synthesis and SAR of Benzisothiazole- and Indolizine-β- d -glucopyranoside Inhibitors of SGLT2
- Discovery of Pyrazolocarboxamides as Potent and Selective Receptor Interacting Protein 2 (RIP2) Kinase Inhibitors
- Studies on the Synthesis of Steroidal Plant-Growth Hormones; XVIII. A Convenient Route to 26,27-Bisnorbrassinolide
- Potent, Selective, and Orally Efficacious Antagonists of Melanin-Concentrating Hormone Receptor 1
- Potent and Selective Ketoamide-Based Inhibitors of Cysteine Protease, Cathepsin K
- 3-Deoxy-3-fluoropyridoxamine 5‘-Phosphate: Synthesis and Chemical and Biological Properties of a Coenzyme B6 Analog
- 6-(4-Chlorophenyl)-3-substituted-thieno[3,2-d]pyrimidin-4(3H)-one-Based Melanin-Concentrating Hormone Receptor 1 Antagonist
- Characterization of a Unique Coenzyme B6 Radical in the Ascarylose Biosynthetic Pathway
- The Structure of Qingjingmycin A Novel Peptide-Type Metabolite of a Hybrid Strain FM3–32 Derived fromStreptomyces qingfengmyceticusandS. hydroscopicus Var. jinggangensis
- Acyclic, orally bioavailable ketone-based cathepsin K inhibitors